These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2707888)

  • 1. IgG and IgE antibodies after immunotherapy with bee and wasp venom.
    Kemeny DM; Lessof MH; Patel S; Youlten LJ; Williams A; Lambourn E
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):247-9. PubMed ID: 2707888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW; Deighton J; Wilson AB; Lachmann PJ
    Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bee venom anti-idiotypic antibody is associated with protection in beekeepers and bee sting-sensitive patients receiving immunotherapy against allergic reactions.
    Khan RH; Szewczuk MR; Day JH
    J Allergy Clin Immunol; 1991 Aug; 88(2):199-208. PubMed ID: 1880320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in IgG and IgE antibody levels to bee venom during immunotherapy.
    Ferrante A; Mocatta F; Goh DH
    Int Arch Allergy Appl Immunol; 1986; 81(3):284-7. PubMed ID: 3770979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological studies of venom immunotherapy.
    Reisman RE; Arbesman CE; Lazell M
    Clin Allergy; 1979 Mar; 9(2):167-74. PubMed ID: 445786
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
    Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of bee venom immunotherapy in children and adolescents.
    Urbanek R; Forster J; Kuhn W; Ziupa J
    J Pediatr; 1985 Sep; 107(3):367-71. PubMed ID: 4032132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee sting allergy in beekeepers.
    Eich-Wanger C; Müller UR
    Clin Exp Allergy; 1998 Oct; 28(10):1292-8. PubMed ID: 9824397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
    Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
    Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose dependence of Hymenoptera venom immunotherapy.
    Golden DB; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1981 May; 67(5):370-4. PubMed ID: 7229226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.
    Engler RJ; Davis WS
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of prolonged venom immunotherapy on serum venom-specific IgE and IgG.
    Clayton WF; Reisman RE; Georgitis JW; Wypych JI; Arbesman CE
    Clin Allergy; 1983 Jul; 13(4):301-7. PubMed ID: 6883662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of antibodies in patients on immunotherapy with insect venoms by immunoblotting.
    Einarsson R
    Int Arch Allergy Appl Immunol; 1987; 83(2):217-9. PubMed ID: 3294603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustered immunotherapy with Yellow Jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters.
    Malling HJ; Djurup R; Søndergaard I; Weeke B
    Allergy; 1985 Jul; 40(5):373-83. PubMed ID: 4037258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of prolonged venom immunotherapy in children.
    Graft DF; Schuberth KC; Kagey-Sobotka A; Kwiterovich KA; Niv Y; Lichtenstein LM; Valentine MD
    J Allergy Clin Immunol; 1987 Aug; 80(2):162-9. PubMed ID: 3611537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.